Alzheimer’s drug lecanemab slows cognitive decline among patients in early stages, study finds

A study released Tuesday showed a closely-watched Alzheimer’s drug slowed cognitive decline among people with early signs of the disease but also carries safety risks for some patients.
The peer-rev…
Read More